SynergEyes Names Dr. Sonsino Director of Clinical Studies

Carlsbad, CA (Feb. 4, 2014) – SynergEyes, Inc., manufacturer and marketer of the Duette® and UltraHealth™ families of contact lenses, has named Jeffrey Sonsino, O.D., F.A.A.O., its new director of clinical studies.

“Dr. Sonsino brings a wealth of expertise, knowledge and clinical skills to this position.  He is well known in the optometric profession as a true leader and innovator in contact lens fitting and care,” said SynergEyes President and CEO James K. Kirchner, O.D. A graduate of the New England College of Optometry, Dr. Sonsino completed his residency in cornea and contact lenses at the Illinois Eye Institute in Chicago. For 11 years, he was an assistant professor at the Vanderbilt Eye Institute. While at Vanderbilt, he founded the Center for Sight Enhancement, was director of the Scleral Lens Clinic and authored nine patents on vision-related medical devices.

A council member of the American Optometric Association’s Contact Lens Section and a Diplomate in the Cornea, Contact Lens and Refractive Therapies Section of the American Academy of Optometry, Dr. Sonsino is in private practice with his wife, Michele Sonsino, O.D., in Nashville, TN.

In a consultative role, Dr. Sonsino will lead SynergEyes’ clinical studies by engaging patients within his practice and by networking with other colleagues around the country when a large number of patients are enrolled in clinical studies.  “My work will add scientific evidence to the clinical observation that the new generation Duette and UltraHealth lenses can be life altering for patients with astigmatism, presbyopia, and irregular corneas,” said Dr. Sonsino. “The new leadership team at SynergEyes is taking this company in a direction that eye care providers will notice.”

About SynergEyes

SynergEyes, the leading global contact lens company dedicated to the independent ECP, manufactures and markets the Duette family of contact lenses for everyday patients seeking exceptional vision. The Duette family includes Duette® and Duette® Multifocal, which are fit with a straightforward empirical fitting approach. SynergEyes is also a world leader in the contact lens market for irregular corneas and recently launched the revolutionary UltraHealth lens, which promotes eye health while giving irregular cornea patients an unprecedented combination of superior vision and all-day comfort.  The SynergEyes portfolio also includes ClearKone®, SynergEyes® A, M, KC, and PS. More information is available at

Christina Kirby
Director of Marketing

Recent Posts

CooperVision Adds SynergEyes to Expand Specialty Contact Lens Adoption

CooperVision Adds SynergEyes to Expand Specialty Contact Lens Adoption

SynergEyes launches SynergEyes VS™ Multifocal Scleral Lens

SynergEyes launches SynergEyes VS™ Multifocal Scleral Lens

Other Line Enhancements include Aberration Control and Limbal Clearance Factor Options

Carlsbad, CA (January 18, 2022) – SynergEyes,...